BACKGROUND: Infants (<12 months) who require liver transplantation (LTx) represent a particularly challenging and understudied group of patients. METHODS: This retrospective study aimed to describe a large single-center experience of infants who received isolated LTx, illustrate important differences in infants versus older children, and identify pretransplant factors which influence survival. More than 25 pre-LTx demographic, laboratory, and operative variables were analyzed using the Log-rank test and Cox proportional hazards model. RESULTS: Between 1984 and 2006, 216 LTx were performed in 186 infants with a mean follow-up time of 62 months. Median age at LTx was 9 months, the majority had cholestatic liver disease, were hospitalized pre-LTx, and received whole grafts. Leading indications for re-LTx (n=30) included vascular complications (43%) and graft nonfunction (40%), whereas leading causes of death were sepsis and multiorgan failure. One-, 5-, and 10-year graft and patient survivals were 75%/72%/68% and 79%/77%/75%, respectively. Relative to older pediatric recipients, infants had worse overall patient survival (P=0.05). The following were significant univariate predictors of graft loss: age less than 6 months and reduced cadaveric grafts; and of patient loss: age less than 6 months, calculated CrCl less than 90, pre-LTx hospitalization, pre-LTx mechanical ventilation, repeat LTx, infants transplanted for reasons other than cholestatic liver disease, and patients transplanted between 1984 and 1994. CONCLUSIONS: Long-term outcomes for infants undergoing LTx are excellent and have improved over time. As the largest, single-center analysis of LTx in infants, this study elucidates a unique set of predictors that can aid in medical decision making.
BACKGROUND:Infants (<12 months) who require liver transplantation (LTx) represent a particularly challenging and understudied group of patients. METHODS: This retrospective study aimed to describe a large single-center experience of infants who received isolated LTx, illustrate important differences in infants versus older children, and identify pretransplant factors which influence survival. More than 25 pre-LTx demographic, laboratory, and operative variables were analyzed using the Log-rank test and Cox proportional hazards model. RESULTS: Between 1984 and 2006, 216 LTx were performed in 186 infants with a mean follow-up time of 62 months. Median age at LTx was 9 months, the majority had cholestatic liver disease, were hospitalized pre-LTx, and received whole grafts. Leading indications for re-LTx (n=30) included vascular complications (43%) and graft nonfunction (40%), whereas leading causes of death were sepsis and multiorgan failure. One-, 5-, and 10-year graft and patient survivals were 75%/72%/68% and 79%/77%/75%, respectively. Relative to older pediatric recipients, infants had worse overall patient survival (P=0.05). The following were significant univariate predictors of graft loss: age less than 6 months and reduced cadaveric grafts; and of patient loss: age less than 6 months, calculated CrCl less than 90, pre-LTx hospitalization, pre-LTx mechanical ventilation, repeat LTx, infants transplanted for reasons other than cholestatic liver disease, and patients transplanted between 1984 and 1994. CONCLUSIONS: Long-term outcomes for infants undergoing LTx are excellent and have improved over time. As the largest, single-center analysis of LTx in infants, this study elucidates a unique set of predictors that can aid in medical decision making.
Authors: V Mazzaferro; C O Esquivel; L Makowka; D Kahn; S Belle; D Kahn; V P Scantlebury; G Ferla; B Koneru; C L Scotti-Foglieni Journal: Transplant Proc Date: 1989-02 Impact factor: 1.066
Authors: H Saing; S T Fan; K L Chan; C M Lo; W I Wei; N S Tsoi; K Y Yuen; I L Ng; M T Chau; W K Tso; J K Chan; J Wong Journal: J Pediatr Surg Date: 1999-11 Impact factor: 2.545
Authors: R M Ghobrial; H Yersiz; D G Farmer; F Amersi; J Goss; P Chen; S Dawson; S Lerner; N Nissen; D Imagawa; S Colquhoun; W Arnout; S V McDiarmid; R W Busuttil Journal: Ann Surg Date: 2000-09 Impact factor: 12.969
Authors: E M Sokal; F Veyckemans; J de Ville de Goyet; D Moulin; N Van Hoorebeeck; D Alberti; J P Buts; J Rahier; L Van Obbergh; P Clapuyt Journal: J Pediatr Date: 1990-08 Impact factor: 4.406
Authors: H M Noujaim; D A Mayer; J A Buckles; S V Beath; D A Kelly; P J McKiernan; D F Mirza; J de Ville De Goyet Journal: J Pediatr Surg Date: 2002-02 Impact factor: 2.545
Authors: C E Broelsch; J C Emond; J R Thistlethwaite; P F Whitington; A R Zucker; A L Baker; P F Aran; D A Rouch; J L Lichtor Journal: Ann Surg Date: 1988-10 Impact factor: 12.969
Authors: J A Goss; C R Shackleton; K Swenson; N L Satou; B J Nuesse; D K Imagawa; M M Kinkhabwala; P Seu; J S Markowitz; S M Rudich; S V McDiarmid; R W Busuttil Journal: Ann Surg Date: 1996-09 Impact factor: 12.969
Authors: Carol Pineda; Tristan Grogan; James A Lin; Joshua J Zaritsky; Robert Venick; Douglas G Farmer; Robert B Kelly Journal: Pediatr Transplant Date: 2015-03-26
Authors: Ryan P Cauley; Khashayar Vakili; Kristina Potanos; Nora Fullington; Dionne A Graham; Jonathan A Finkelstein; Heung Bae Kim Journal: Liver Transpl Date: 2013-07 Impact factor: 5.799
Authors: Noelle H Ebel; Evelyn K Hsu; André A S Dick; Michele L Shaffer; Kristen Carlin; Simon P Horslen Journal: J Pediatr Date: 2020-06-22 Impact factor: 6.314
Authors: Stephanie Keeling; Malcolm F McDonald; Adrish Anand; Jordan Dunson; Elizabeth Williams; Theodore Zhang; Brian Hickner; Nhu Thao Nguyen Galván; Christine O' Mahony; John A Goss; Abbas Rana Journal: Can J Gastroenterol Hepatol Date: 2022-09-17